Indicator 2 Incidence of selected cancers — Key amendments Data have been backcast due to revised Estimated Resident Population from previous cycle (ERP) data. of reporting: Data for 2009 have also been re-supplied for NSW and the ACT to replace previous estimates. Outcome: Australians are born and remain healthy. Measure: Incidence of selected cancers of public health importance For melanoma, lung and bowel cancer, the measure is defined as: numerator number of new cases in the reported year — denominator total population — and is expressed as a directly age standardised rate (per 100 000 population) For breast and cervical cancer in females, the measure is defined as: numerator number of new cases in women in the reported year — denominator total female population — and is expressed as directly age standardised rates (per 100 000 population) Variability bands are calculated for data by State/Territory (for within jurisdiction comparisons only cannot be used to compare across – jurisdictions). Calculated separately for each type of cancer Data source: Numerator Australian Cancer Database — Denominator ABS Estimated Resident Population (total population — – 2011 Census base) and ABS Indigenous experimental estimates and projections (Indigenous population 2006 Census base). For comparisons – of Indigenous and non-Indigenous populations, all data will be 2006 Census based. Data are available annually Data provider: AIHW Data availability: 2010 and (2009, 2008, 2007 and 2006 backcast for revised ERP except — for Indigenous status for which revised data are not available until 2014, and therefore only backcast for 2009 for re-supply of ACT and NSW) Cross tabulations State and Territory (for each cancer type), by: provided: Indigenous status remoteness (ASGC) SEIFA IRSD quintiles (based on 2006 SEIFA) Nationally (for each cancer type), by SEIFA IRSD deciles
Indicator 2 — Incidence of selected cancers Key amendments from previous cycle of reporting: Data have been backcast due to revised Estimated Resident Population (ERP) data. Data for 2009 have also been re-supplied for NSW and the ACT to replace previous estimates. Outcome: Australians are born and remain healthy. Measure: Incidence of selected cancers of public health importance For melanoma, lung and bowel cancer, the measure is defined as: numerator — number of new cases in the reported year denominator — total population and is expressed as a directly age standardised rate (per 100 000 population) For breast and cervical cancer in females, the measure is defined as: numerator — number of new cases in women in the reported year denominator — total female population and is expressed as directly age standardised rates (per 100 000 population) Variability bands are calculated for data by State/Territory (for within jurisdiction comparisons only – cannot be used to compare across jurisdictions). Calculated separately for each type of cancer Data source: Numerator — Australian Cancer Database Denominator — ABS Estimated Resident Population (total population – 2011 Census base) and ABS Indigenous experimental estimates and projections (Indigenous population – 2006 Census base). For comparisons of Indigenous and non-Indigenous populations, all data will be 2006 Census based. Data are available annually Data provider: AIHW Data availability: 2010 and (2009, 2008, 2007 and 2006 backcast for revised ERP — except for Indigenous status for which revised data are not available until 2014, and therefore only backcast for 2009 for re-supply of ACT and NSW) Cross tabulations provided: State and Territory (for each cancer type), by: Indigenous status remoteness (ASGC) SEIFA IRSD quintiles (based on 2006 SEIFA) Nationally (for each cancer type), by SEIFA IRSD deciles
healthcare-agreement-2012-13.docx